feed,title,long_url,short_url
ðŸ’°Barrons,"This Weight-Loss Stock Sank After Earnings. Itâ€™s Still a Risk for Eli Lilly, Novo Nordisk.",https://barrons.com/articles/this-weight-loss-stock-sank-after-earnings-its-still-a-risk-for-eli-lilly-novo-nordisk-daadd773?mod=RTA,
